KZIA Kazia Therapeutics ADRs

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, engaged in developing anti-cancer drugs. It has two clinical staged drug development candidates and an early stage discovery program. This is an ADR of a company whose stock trades outside of the U.S. as the symbol AT:KZA.

$1.11  -0.01 (-0.89%)
As of 09/30/2022 11:49:37 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Australia
Country of incorporation:  Australia
IPO date:  02/11/2013
Outstanding shares:  15,031,604
Average volume:  66,692
Market cap:   $16,835,396
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.57
PS ratio:   395.88
Return on equity:   -53.49%
Net income %:   -32,065.43%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy